Amoxicillin, an antibiotic that is widely prescribed for various infections, is associated with a very low rate of drug-induced liver injury; hepatitis and cholestasis are rare complications. Here we present a case of a 39-year-old woman who was diagnosed with abdominal actinomycosis and received amoxicillin treatment. The patient displayed hepatocellular and bile-duct injury, in addition to elevated levels of liver enzymes. The patient was diagnosed with amoxicillin-induced cholestatic hepatitis. When amoxicillin was discontinued, the patient's symptoms improved and her liver enzyme levels reduced to near to the normal range. 
INTRODUCTION
Amoxicillin is a rare cause of drug-induced liver injury. [1] [2] [3] Clinical course of hepatocellular injury by amoxicillin is usually benign. The abnormalities resolve within a few months following discontinuation of amoxicillin treatment.
A retrospective study from the United Kingdom estimated that liver injury from amoxicillin occurs in approximately 0.3 cases per 10,000 treated patients. 4, 5 When identified early and treated appropriately, the prognosis is excellent. However, because of its low occurrence, amoxicillin-induced liver injury has sometimes been overlooked. In such cases, severe injury and even death have been reported due to progressive liver failure and hepatic bile duct injury. 6 We report a case of a 39-year-old woman who developed cholestatic hepatitis with bile duct damage and hepatocellular injury following amoxicillin treatment for abdominal actinomycosis.
CASE REPORT
A 39-year-old woman with no significant clinical history was admitted to the hospital with a distended abdomen and weight (0.83-1.2); and the total protein level was 6.5 g/dL (6-8.2 g/dL). (Fig. 2) .
DISCUSSION
Drug-induced hepatitis is a common cause of liver injury and acute liver failure, particularly in patients treated with antibiotics. 7, 8 Amoxicillin causes liver injury in 0.3 of 10,000 prescriptions.
However, when prescribed in combination with clavulanate, the incidence of amoxicillin-induced liver injury increases to 1.7 in 10,000 prescriptions. amoxicillin/clavulanate hepatotoxicity is unknown. However, the clavulinic acid of amoxicillin/clavulanate combination therapy has been implicated as the cause of hepatotoxicity, as re-challenge with amoxicillin alone is typically well tolerated compared with amoxicillin/clavulanate. 5 Furthermore, clavulanic acid combined with other β-lactams can also lead to liver injury. 9 Thus, liver injury with these therapies is most likely an idiosyncratic reaction to amoxicillin.
Amoxicillin is an oral semi-synthetic penicillin with a broader spectrum of activity than other penicillins. Amoxicillin distributes to the liver, lungs, gallbladder, and prostate, where it can mildly elevate liver enzyme levels and produce jaundice and abnormalities of bile secretion. Liver injury is a rare side effect of amoxicillin treatment. 10, 11 Pathology evaluation is helpful for the diagnosis of drug-induced liver injury. Severe cases of amoxicillin-induced liver injury, some resulting in death, have been associated with progressive liver failure and the vanishing bile duct syndrome. 12, 13 In 1996, García Rodríquez et al 5 In the present case, the patient had no significant medical history and was not receiving any other drug except amoxicillin;
there were no significant abnormalities on laboratory testing.
There are no specific guidelines for the clinical evaluation to diagnose drug-induced liver injury, but the scales often used for causality include the CIOMS and CDS. In the present case, these scales indicated "probable" and "possible" liver injury, in support of the diagnosis. In addition, the findings of hepatocellular injury, cholestasis, and the loss of bile duct were identified on liver biopsy. Consequentially, the patient was diagnosed with cholestatic hepatitis associated with amoxicillin. The symptoms and laboratory findings improved after the amoxicillin was discontinued.
Compared with the amoxicillin/clavulanate regimen, treatment with amoxicillin alone as a cause for liver injury is rare. In addition, diagnosing drug-induced liver injury is problematic because of its vague symptoms and lack of definite diagnostic guidelines. Amoxicillin is well known as a safe drug even when administered to patients with chronic liver disease or cirrhosis. 15 Therefore, amoxicillin-induced liver injury may not be suspected at an early stage, as in the present case. However, when liver injury occurs, hepatocellular liver injury is common. 5 In the case reported here, liver biopsy and laboratory findings showed significant bile duct injury and cholestatic hepatitis. The vanishing bile duct syndrome has been reported as a cause of death in a patient with amoxicillin-induced liver injury. 6 For most cases of drug-induced hepatotoxicity, the prognosis is good when the drug is discontinued. Nevertheless, it is important to consider that liver failure and death can occur with inappropriate patient management. Thus, patients receiving amoxicillin should be closely monitored for signs of bile duct injury or cholestatic hepatitis resulting from amoxicillin-induced liver injury.
Several current and newly developed drugs can lead to liver injury, but studies investigating drug hepatotoxicity are rare. In the majority of cases, the prognosis is good when administration of the drug is discontinued. However, the administration of well-tolerated drugs such as amoxicillin can lead to liver failure and death in rare cases. Physicians should continue to monitor the potential hepatotoxicity of drugs, even drugs with a very low prevalence of liver toxicity.
